Zuoxiang XIao

Title: Zuoxiang Xiao: Innovator in Antibody Therapeutics

Introduction

Zuoxiang Xiao is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

Zuoxiang Xiao's latest patents include groundbreaking research on the therapeutic use of antibodies against ENPP3. The first patent discloses monoclonal antibodies against ENPP3, bispecific antibodies against ENPP3 and CD3, as well as nucleic acids that encode these antibodies. It also covers vectors and host cells that incorporate these nucleic acids, along with pharmaceutical compositions and conjugates that utilize the antibodies. The second patent reiterates these findings, emphasizing the potential therapeutic methods for using these antibodies in clinical applications.

Career Highlights

Zuoxiang Xiao is currently associated with Zhejiang Shimai Pharmaceutical Co., Ltd. His work at the company has positioned him as a key player in the development of novel therapeutic strategies. His research is aimed at addressing critical medical needs through innovative antibody therapies.

Collaborations

Zuoxiang collaborates with notable colleagues, including Jiaping Peng and Dongwen Zhou. Their combined expertise enhances the research and development efforts at Zhejiang Shimai Pharmaceutical Co., Ltd.

Conclusion

Zuoxiang Xiao's contributions to antibody therapeutics represent a significant advancement in biotechnology. His innovative patents and collaborative efforts continue to pave the way for new medical treatments.